Miriam Kim, MD

Miriam Kim, MD

Medical Oncologist

Primary Academic Title

Assistant Professor of Medicine, Division of Oncology, Washington University School of Medicine

Clinical Expertise


Research Interest

Developing genetically modified T cells for therapy of acute myeloid leukemia


  • 2008: MD, Seoul National University, South Korea


  • 2008 - 2011: Resident, internal medicine, SUNY Downstate Medical Center, Brooklyn, New York
  • 2011 - 2014: Fellow, hematology and oncology, University of Southern California, Los Angeles
  • 2014 - 2017: Postdoctoral researcher, University of Pennsylvania, Philadelphia

Board Certification

  • 2011: American Board of Internal Medicine
  • 2014: American Board of Internal Medicine - hematology
  • 2014: American Board of Internal Medicine - oncology

Selected Research Publications

An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies.
  • Xiang J, Devenport JM, Carter AJ, [...] Kim MY, [...] DiPersio JF
  • Leukemia 2023
Flotetuzumab and other T-cell immunotherapies upregulate MHC class II expression on acute myeloid leukemia cells.
  • Rimando JC, Chendamarai E, Rettig MP, [...] Kim M, [...] DiPersio JF
  • Blood 2023
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
  • Ferraro F, Gruszczynska A, Ruzinova MB, [...] Kim MY, [...] Welch JS
  • Haematologica 2022
CD7-deleted hematopoietic stem cells can restore immunity after CAR T cell therapy.
  • Kim MY, Cooper ML, Jacobs MT, [...] DiPersio JF
  • JCI Insight 2021

View All Publications

Contact Information

  • Washington University Medical Campus

    4921 Parkview Place
    Saint Louis, MO 63110

Phone Numbers

Request an appointment